Integrated Services for PWID: person-centered care for HIV in Zambia
Official title: Integrated Services for PWID using Person-centered Interactions, Reach, and Engagement (INSPIRE)
Funded at University of Maryland Baltimore · NIH-11455236 · Data updated 2026-11-12
A patient-focused project in Zambia will test a person-centered, integrated care approach to help people who inject drugs access HIV testing, linkage to care, and ongoing treatment.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Maryland Baltimore NIH-funded |
| Lab location | 1 site (Baltimore, United States) |
| Project start | September 30, 2025 |
| Project end | July 31, 2028 |
| Funding year | 2026 |
| Award (this year) | $37,085 |
| NIH project number | 3R34DA062543-02S1 |
| Project ID | NIH-11455236 on NIH RePORTER |
Who could benefit from this research
✓Could help
Adults who inject drugs in Zambia and who are engaging with or awaiting HIV or MOUD services.
✕Less likely to help
People not living with HIV or not using MOUD may have limited direct benefit.
What this research studies
This project aims to co-adapt and pilot an integrated HIV care model for people who inject drugs in Zambia, focusing on start-to-finish support from testing to viral suppression. It will explore how MOUD (medications for opioid use disorder) can be combined with HIV services in real clinics, with attention to patient experiences and system-level delivery. Researchers will test feasibility, acceptability, and preliminary effectiveness of the integrated care model within the local health system.
Why it matters
Potential benefit: If successful, the model could improve HIV testing, treatment initiation, and viral suppression among PWID, reducing transmission and improving health outcomes.
How similar studies have gone: There is limited evidence on MOUD-HIV care integration in sub-Saharan Africa; this study builds on a developing area with promising but early results.
Where this research is happening
-
University of Maryland Baltimore
Baltimore, United States Active
Researchers
- Principal investigator: Lavoie, Marie-Claude Caroline — University of Maryland Baltimore
- Study coordinator: Lavoie, Marie-Claude Caroline
Related research
Other NIH-funded projects on the same topics.
-
Resilient HIV Implementation for LGBTQ Youth in Africa and Beyond
A program to help young people ages 15–24 who are at risk for or living with HIV, especially sexual and gender minority youths, access better HIV prevention and care through real-world health practice improvements.
-
Algorithms to find HLA-E neoantigens for cancer immunotherapy
Aims to develop computer methods to discover tumor-specific targets presented by HLA-E to guide new T cell therapies for cancer.
-
NPRL2 loss and focal cortical dysplasia in epilepsy
This grant investigates how losing NPRL2 in the brain contributes to focal cortical dysplasia and epilepsy in children.
-
New way to make head and neck cancer treatments work better
A research project at the University of Maryland Baltimore aims to improve treatment for advanced head and neck cancer, with a focus on making cisplatin and newer therapies work better while reducing kidney side effects.
-
Genetics and function of inherited brain disorders that affect thinking and behavior
Scientists are studying how genes and cellular helpers shape brain development and why certain kids have intellectual disabilities and adaptive-behavior challenges.
-
Finding broadly protective antibodies against Crimean-Congo Hemorrhagic Fever
Researchers will study blood from people who survived CCHF to find human antibodies that protect against multiple virus variants, with early tests in animal models to check their breadth.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.